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Abstract
Human papillomavirus (HPV) DNA is preferentially found in spontaneous abortions, specifically residing in trophoblasts, and transfected
HPV-16 DNA replicates and produces progeny in 3A trophoblasts in culture. In this study 3A trophoblasts were shown to display both HPV
receptors and infection by HPV-31b and HPV-6 virus resulted in de novo (increasing) HPV DNA replication in these cells (inhibited by
neutralizing anti-HPV31b antibodies). Reverse transcription-polymerase chain reaction analysis revealed that E1ˆE4, E6, and L1 were
significantly expressed at days 5 (early) and 10 (late), respectively, and in situ immunocytochemistry verified L1 protein expression. Perhaps
most important, HPV 31b virus infection caused both a decrease in 3A trophoblast cell numbers in a dose-dependent manner and a low
trophoblast-endometrial cell adhesion (both inhibited by neutralizing anti-HPV-31 antibodies). These data further support the hypothesis that
HPVs are fully active in trophoblasts and may cause some spontaneous abortions.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Human papillomaviruses (HPVs) are well known for
being associated with cervical cancer and have been thought
to be an exclusively keratinocyte/skin-specific virus. How-
ever, there have been a number of clinical and molecular
studies which indicate HPV commonly infects placental/
fetal material and has some relationship to spontaneous
abortions (Marnavi et al., 1992; Pao et al., 1995; Sikstrom et
al., 1995; Malhomme et al., 1997; Hermonat et al., 1997,
1998, 1999). For example, Malhomme et al. have found that
70% of spontaneous abortion specimens contain HPV by
PCR analysis (Malhomme et al., 1997). Pao et al. also found
HPV-18 in 18% of hydatidiform moles and 50% of chori-
ocarcinomas (malignant trophoblasts) (Pao et al., 1995).
Sikstrom et al. observed that women with a history of HPV
infection had a higher risk of spontaneous abortion (odds
ratio of 3) (Sikstrom et al., 1995). An earlier study by our
laboratory also found that HPV infection is three fold more
prevalent in spontaneous aborted products of conception
than elective abortions (60 vs 20%), and direct analysis of
spontaneous abortion tissues by in situ PCR revealed that
trophoblasts were the preferential target for HPV infection
of the placenta (Hermonat et al., 1997, 1998). Moreover,
more recently we have found that HPV-16 DNA is able to
de novo replicate and produce progeny virions upon trans-
fection in cultured 3A placental trophoblasts (Liu et al.,
2001). However, there are two groups who find no evidence
of HPV in spontaneous abortions or the placenta (Genest et
al., 1999; Eppel et al., 2000).
Being one of the most critical tissues of the placenta, the
trophoblast layer plays an important role in contacting ma-
ternal tissues and serves multiple roles in the gestation. It is
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thus not surprising that disruption of the trophoblast layer,
by HPV or any other infectious or chemical agent, might
result in abnormal placentation, even expulsion of the ges-
tation (Clark et al., 1993). Our most recent study introduced
the HPV-16 E6 and E7 oncogenes, both alone and in com-
bination, into 3A trophoblasts by adenoassociated virus
gene transfer. The results demonstrate that multiple tropho-
blast-cytopathologies result, including trophoblast death,
weakened trophoblast-endometrial cell binding, and immor-
talization (You et al., 2002).
The ability to synthesize HPV virus in the laboratory was
achieved 10 years ago by growing a latently HPV-31b-
infected cell line (CIN612-9E) in organotypic epithelial raft
cultures (Meyers et al., 1992; Meyers, 1996). This culture
system generates a successful keratinocyte differentiation
program which allows HPV to express all of its genes in the
natural temporal order and to replicate and produce viral
progeny. Our recent synthesis of HPV-16 in 3A tropho-
blasts, by genomic HPV-16 DNA transfection in simple
submerged cell monolayer culture, represents a new method
for generating HPV and studying HPV biology in the lab-
oratory, but the HPV/3A assay may also represent a new
model system for studying the potential association of HPV
with trophoblastic pathology and spontaneous abortion (Liu
et al., 2001).
In this study we use and extend this HPV/3A model
system to investigate the affects of HPV-31b virus infection
upon 3A trophoblasts. Using HPV infection improves our
model to more fully mimic the in vivo situation. Further-
more introducing a subset of HPV genes into trophoblasts
does not represent the complete viral genome, which con-
tains all its genes and which allows for natural temporal
gene regulation and expression. It is demonstrated here that
HPV-31b virus can infect 3A trophoblasts in culture, can de
novo replicate in these cells, and had multiple trophoblastic
cytopathologies results. These cytopathologies, resulting
from whole virus infection, include lower trophoblast cell
numbers and significantly weakened trophoblast-endome-
trial cell adhesion.
Results
Trophoblasts express the HPV receptors
For trophoblasts to be hosts for HPV infection the 3A
cells must most likely express the HPV receptors which are
usually necessary for binding by HPV virus particles. Hepa-
ran/heparan sulfate (Giroglou et al., 2001) and possibly
alpha6 integrin (Yoon et al., 2001) may be candidate recep-
tors for HPV virions. The presence of these two molecules
on the surface of 3A trophoblasts was analyzed by FACS.
Fig. 1 shows that 3A trophoblasts express both of these
molecules, with alpha6 integrin expression likely being ex-
pressed at higher levels.
HPV-31b virion infection results in de novo DNA
replication, RNA, and protein expression
HPV-31b was chosen for study as it is highly related to
HPV-16 and because of the existence of the 612 cell line
which harbors HPV-31b and from which we could generate
HPV-31b virus (Meyers et al., 1992; Meyers, 1996). HPV-
31b virus stocks were generated by processing mature 12-
day organotypic epithelial raft (skin) cultures of 612, similar
to that described by others (Ozbun, 2002). Fig. 2A shows
the process of generating the virus stock, and the virus stock
was utilized as both a “rough” (filtered cell lysate) stock and
as a CsCl gradient-purified stock as described further under
Materials and methods. The CsCl-purified virus stock con-
tained approximately 109 encapsidated genomes (eg) per
milliliter; rough virus stock contained 108 eg per milliliter
by DNA Southern blot analysis (Fig. 2B). Next, the rough
virus stock was then used to infect 3A trophoblasts, with
total cellular DNA harvested at 15 days postinfection, sep-
arated by agarose gel electrophoresis, and analyzed by
Southern blot for HPV-31b DNA. Also included in this
experiment was the pretreatment of the putative virus stock
with known anti-HPV-31 or anti-HPV-6 neutralizing anti-
bodies. Day 15 was chosen for harvesting the cells as this is
the approximate peak time seen for HPV-16 DNA replica-
tion seen resulting from DNA transfection (Liu et al., 2001).
Fig. 1. Expression of HPV receptors by 3A trophoblasts. HPV candidate
receptors heparan sulfate and alpha6 integrin were analyzed by FACS
using appropriate antibodies. (A) Heparin sulphate expression in 3A tro-
phoblasts compared to isotype control. (B) Integrin alpha-6 expression in
3A trophoblasts compared to isotype control.
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The results, shown in Fig. 2C, indicate significant levels of
HPV-31b DNA were present on day 15, and that the infec-
tion of 3A cells could be neutralized in a dosage-dependent
manner using known, specific anti-HPV-31 neutralizing an-
tibodies. The inactivation of replication by the specific anti-
HPV31 neutralizing antibody indicates that the replication
was due to HPV-31b virion infection.
To further document the ability of our HPV-31b virus
stock to infect and replicate in 3A trophoblasts, a time
course of infection was undertaken in a more detailed man-
ner using both rough (Fig. 3A) and purified HPV-31b (Fig.
3B) virus stocks, similar to Fig. 2C. Southern blot analysis
of total cellular DNA resulting from infection by both HPV-
31b virus stocks gave similar results. Both infections
showed increasing HPV-31b DNA replication levels over
time. As equal amounts of total cellular DNA were loaded
from each time of harvest, the increased HPV signal indi-
cates that de novo HPV-31b DNA replication is occurring.
Another Southern blot analysis (Fig. 3C) demonstrated suc-
cessful HPV-6 virus infection and DNA replication (HPV-6
virus was obtained from Dr. William Bonnez; Bonnez et al.,
1993). In this experiment 3A trophoblast monolayers were
infected with HPV-6 virus stock (a rough virus stock) and
total cellular DNA was isolated at 14 days postinfection.
Note that, similar to Figs. 3A and B, the infected cells
contained the HPV-6 genome, while uninfected cells did
not. Thus both HPV types 31b and 6 could infect and
replicate in 3A trophoblasts.
Next, an analysis of transcriptional activity during HPV-
31b infection was undertaken. RT-PCR analysis of early
and late mRNA expression demonstrates that significant E6
RNA (Fig. 4A) was expressed from day 5 to 20, while L1
mRNA (Fig. 4B) expression was delayed until day 10, later
than E6. E1
ˆ
E4 spliced transcripts, which span an intron
and estimated size of 349 bp, was similar to E6 expression
from day 5 to 20 (Fig. 4C). The control, TFIIB, was rela-
tively stable over the time course. The mRNA samples were
also analyzed by direct PCR and failed to generate products
(data not shown).
The infected 3A trophoblasts were also cultured on slides
for immunohistochemical analysis for late L1 protein ex-
pression using primary anti-L1 antibody. It was shown
(Figs. 5B and C) that significant numbers of the infected 3A
trophoblasts expressed L1 protein. In comparison the unin-
Fig. 3. HPV-31b DNA replication in 3A trophoblast by infection. The
following HPV-31b replication experiments (each done at least three
times) were carried out similar to Fig. 2C with the exception that multiple
times of harvest were done. (A) A time-course Southern blot analysis of
HPV-31b DNA replication resulting from rough virus (without CsCl pu-
rification) infection of 3A trophoblasts. Note that HPV-31b DNA levels
increase over time. (B) A time-course Southern blot analysis of CsCl-
gradient purified HPV-31b virus infection in 3A trophoblasts. Note that,
similar to Fig. 3A, HPV-31b DNA levels increased over time, indicating
that de novo HPV-31 DNA replication was taking place. (C) For HPV-6
infection 3A trophoblast monolayer (1  106 cells) was infected with 0.5
ml of HPV-6 virus stock and total cellular DNA isolated at 14 days
postinfection. Note that, similar to HPV-31b, high levels of HPV-6 DNA
are seen at 2 weeks postinfection.
Fig. 2. Generation of HPV-31 virus stock and titering. HPV-31b virus stock
was generated by mincing and grinding 12-day-old skin rafts from
CIN6129E cells, which harbor episomal HPV-31b. The virus stocks were
treated with DNase I and titered. (A) The experimental scheme for showing
the procedure of making HPV 31b virus. (B) The Southern blot analysis for
titering virus stock of CsCI purification and cell lysate without CsCl
purification as rough virus; it was shown that the CsCl-purified virus stock
contained approximately 109 encapsidated genomes (eg) per ml. Rough
virus stock contained 108 eg per ml by DNA Southern blot hybridization.
(C) The neutralization of the HPV-31b virus stock by specific antibody.
HPV-31b virus stocks (2 X 106 eg) were pretreated with neutralizing
anti-HPV-31 antibodies, or anti-HPV-6 antibodies, or untreated, before
infecting 3A trophoblasts (1 X 105) overnight. The next day the cells were
trypsinized (this also removes unabsorbed virus from the cell surface) and
replated in fresh medium. DNA was harvested on day 15. Note that
HPV-31 infection of 3A cells was neutralized in a dosage-dependent
manner and blocked using known, specific anti-HPV-31 neutralizing anti-
bodies.
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fected cells displayed no signal (Fig. 5A). Most of the dark
brown color, representing L1 protein, was observed in the
nuclei of the cells, with a lower signal occurring in the
cytoplasm.
HPV-31b infection reduces trophoblast cell numbers
Our central hypothesis is that HPV virus infection may
cause trophoblast cytopathology which would then, in turn,
result in trophoblast failure and gestational loss. To observe
any resulting cytopathology, 3A trophoblasts were infected
with HPV-31b virus at an m.o.i. of 0.5, 5, 50, or 500 eg per
cell, in quadruplicate. Monolayer 612 cell lysates, generated
from similar 612 cell numbers as 612 cells from the raft,
were used as a virus negative control. These lysate/cells
would not contain HPV-31b virus as these keratinoctes were
not allowed to differentiate. Another control was uninfected
3A trophoblasts. The cultures were followed over time and
a representative experiment (of three) is shown in Fig. 6A
and quantitated in Fig. 6B. In the HPV-31b-infected cells it
was found that some of the trophoblasts changed to a round
shape and detached from the culture plate at day 6 postin-
fection compared to controls and uninfected control parental
3A cells. HPV-31b-infected 3A cultures consistently dis-
played significantly lower cell numbers in a dose-dependent
manner. Thus, HPV-31b infection did result in a form of
cytopathology, that is, lower cell numbers. To verify that
this effect was due to HPV-31b virus infection, trophoblasts
were again infected with HPV-31b virus stocks; however,
some virus stocks were pretreated with known neutralizing
anti-HPV-31 antibodies before infection. The top of Fig. 7
shows a representative experiment (of three), while the
bottom shows a quantification of the results. As is seen, the
specific neutralizing anti-HPV-31 antibodies were able to
inhibit the decreasing cell number effect by HPV-31b virus
infection. Finally, to investigate if this effect was a general
effect on cells or trophoblast-specific, the same HPV-31b
virus, at m.o.i.s of 0.5, 5, 50, or 500 eg/cell, were used to
infect three other cell lines: primary human fibroblasts, and
RL95 and HEC uterus endometrial cells, in quadruplicate.
As can be seen in Fig. 8, there was no significant decrease
in cell number in any of these three cell lines. Thus the
HPV-31b/reduced cell number effect appears to be tropho-
blast-specific.
HPV-31b infection and transfection reduces trophoblast-
endometrial cell adhesion
Perhaps the most critical role of the trophoblast is to
anchor the placenta to the maternal endometrium. We have
previously published that the HPV-16 E6 and E7 oncogenes
have a strong affect on 3A trophoblasts, decreasing their
ability to bind to endometrial epithelial cells (You et al.,
2002). However, this study utilized component genes of
HPV, but not the whole viral genome in its natural arrange-
ment. Thus, to determine the effect of natural HPV-31b
virus infection upon trophoblasts, 3A cells were untreated,
treated with lysate, or infected with HPV-31b virus (m.o.i.
100 eg/cell); 612 cell monolayer lysates were used as a
virus-negative control. A lymphoblastoid cell line (LCL)
and primary human fibroblasts served as negative and pos-
itive controls, respectively. The treated 3A cells were tested
for binding to HEC cells at 2 weeks postinfection and the
results are shown in Fig. 9 at 1 h (Fig. 9A) and 3 h (Fig. 9B)
binding. As can be seen HPV-31b viral infection did result
in a significantly lower, defective binding of the 3A cells to
the HEC monolayer endometrial cells. This effect could be
inhibited by using neutralizing anti-HPV-31 antibodies,
which in turn allowed for high 3A trophoblast binding of
endometrial cells. We further carried out a PCR analysis of
HPV DNA in the starting cells, and the nonadherent and
adherent HPV-infected 3A cell populations. These data di-
rectly show that both endometrial-bound and unbound
HPV-31b-infected 3A trophoblasts were positive for HPV-
31. However, the level of HPV-31b DNA was higher in the
unbound cells. A repeat of these experiments using the
RL95 endometrial cancer cells in place of HEC gave similar
results (data not shown).
Discussion
This study demonstrates that HPV-31b and HPV-6 can
infect and replicate in 3A trophoblasts. Also demonstrated
in this study are two effects on 3A trophoblasts due to
HPV-31b infection. These are decreased trophoblast cell
Fig. 4. HPV-31b mRNA expression in 3A trophoblast by RT-PCR. (A) A
representative RT-PCR analysis of E6 expression (one of three such experi-
ments). Note that significant E6 RNA (399 bp) expression from days 5 to 20.
(B) A representative RT-PCR analysis of L1 expression. Note that significant
L1 expression (451 bp) was delayed until day 10, later than E6. (C) E1ˆE4
spliced transcript expression (349 bp) (representative of three such experi-
ments) was similar to E6 expression started from day 5 until day 20. TFIIB
(958 bp) was relatively stable over the time course. The mRNA samples were
also analyzed by direct PCR and failed to generate products (data not shown).
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numbers and weakened binding to endometrial cells. Our
finding of resulting lower 3A trophoblast cell numbers, in a
dosage-dependent manner, upon HPV-31b viral infection, is
strongly suggestive of a type of cytopathology. Whether
HPV-31b is limiting cell growth, killing these cells outright,
or causing their loss is yet unclear. Our previous study on
the effects of HPV-16 E6 and E7 gene expression suggests
that cell death is a significant possibility (You et al., 2002).
To our knowledge HPV-31b, or related HPV-16, when
introduced as a complete genome has never been associated
with cell-cycle arrest or lower cellular growth rates. Usually
HPV is associated with the inverse, increased cell growth,
oncogenic transformation. Yet the issue remains unclear as
to what the mechanism is which results in lower cell num-
bers. However, these resulting lower cell numbers, if they
occur in vivo as a result of HPV infection, could have a
significant impact on the gestation. The placenta-endome-
trium interface might be significantly affected if half of the
trophoblasts are lost through death or lower growth. Thus
our 3A growth assay may represent a new model for study-
ing potential placental/trophoblast damage by HPV.
We have previously shown that both HPV-16 E6 and E7
genes have a significant effect upon 3A trophoblast-endo-
metrial cell adhesion. In this study we demonstrate HPV-
31b viral infection of 3A weakens trophoblast-endometrial
cell adhesion, which is consistent with and extends this
earlier data. Our new data using virus infection represent a
potentially more valid result, possibly more related to the in
vivo situation. We think this for two reasons. First, we are
studying the complete HPV genome, not isolated compo-
nent genes. The regulation of viral genes is complicated and
the study of forced expression of a single gene at high levels
may introduce flaws into the assay and produce results
which may not represent the in vivo situation. Second, the
viral DNA is being introduced by virus infection, the most
“natural” route. Likely this means low initial expression and
resulting natural gene regulation, in sharp contrast to “force
feeding” the cell by DNA transfection with a strong pulse of
gene expression. In any case, the introduction of the full
HPV-31b genome does weaken trophoblast-endometrial
cell binding, and our previous study does map the effect to
specific genes. The combination of pathologies we observe
are potentially significant and possibly synergistic in causing
damage to the gestation. Lower trophoblast cell numbers, and
weaker endometrial binding by the remaining cells on a per
cell basis, can only be seen as dangerous to the fetus.
Fig. 5. Immunocytochemistry of L1 expression in trophoblast. Uninfected (5A) and HPV-31b virus-infected (B and C) 3A trophoblasts were fixed and stained
using the anti-L1 antibody at 15 days postinfection as described under Materials and methods. (A) Uninfected 3A cells negative for L1 protein (negative
control). (B) HPV-31b virus-infected 3A trophoblast to be L1-positive upon anti-L1 antibody staining (brown color). Most of the staining was observed in
the nuclei of the cells, with a lower signal occurring in the cytoplasm. (C) A higher power picture of the L1 signal in nuclei.
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HPV are DNA viruses which infect keratinocytes and are
strongly linked to cervical cancer and other pathologies. Our
findings of HPV activity in trophoblasts may possibly be the
uncovering of a “second world” of HPV biology and pa-
thology. The new data presented here are fully consistent
with our hypothesis that HPV infection of trophoblasts may
be linked to some spontaneous abortion. This laboratory
data are also consistent with two more epidemiologically/
clinically oriented studies which demonstrate that 60–70%
of spontaneous abortions contain HPV (Malhomme et al.,
1997; Hermonat et al., 1997). This study supports and ex-
tends our previous study that transfected HPV-16 DNA can
replicate in 3A trophoblasts (Liu et al., 2001). The finding
that 3A trophoblasts express HPV receptors also supports
our previous studies, demonstrating that HPV are preferen-
tially found in the cells of the trophoblast layer of sponta-
neous abortions. Evidence shown here that HPV-31b infec-
tion decreases trophoblast cell numbers and decreases
trophoblast-endometrial cell adhesion are also consistent
with our previous studies (You et al., 2002). All these data,
taken together, strongly suggest that HPV can infect pla-
cental trophoblasts and are associated with spontaneous
abortion. If the HPV–spontaneous abortion link is further
validated, we think that the HPV-31b infection protocolFig. 6. HPV-31b infection is associated with trophoblast cytopathology.
(A) A representative experiment of the four carried out is shown. 3A
trophoblast were infected with HPV-31b virus at an M.O.I. of 0.5, 5, 50, or
500 eg per cell, in quadruplicate. Monolayer 612 cell lysate, generated
from similar CIN612 cell numbers as 612 cells from the raft, were used as
a virus negative control. Another control was uninfected trophoblasts. All
the cells were fixed by formalin and stained with methylene blue and
analyzed by densitometer. It could be seen microscopically that some of the
trophoblasts changed to a round-shape and detached from the culture plate
at day 6 after HPV-31b infection compare. 612 cell lysate-infected and
control 3A cells did not show this change. HPV-31b-infected 3A cultures
consistently displayed significantly lower cell numbers in a dose-dependent
manner. (B) A quantitative analysis of the four experiments, again showing
the dosage response of lower cell numbers resulting from HPV-31b infec-
tion.
Fig. 7. Neutralizing antibodies inhibit HPV-31b-induced trophoblast cyto-
pathology. 3A trophoblasts were infected with HPV-31b virus stocks
which were either not treated or pretreated with HPV-31 neutralizing
antibodies before infecting the trophoblasts, as indicated. Note that the
specific neutralizing antibodies inhibited the decrease in cell numbers
caused by HPV-31b infection.
Fig. 8. HPV-31b infection is not associated with fibroblast and endometrial
cell cytopathology in culture. As in Fig. 6, HPV-31b virus were used to
infect primary human fibroblast or two human uterine endometrial cell
lines, in quadruplicate. Note that there was no significant decrease in cell
numbers within these three cell lines due to HPV-31b as was found for 3A
trophoblasts in Fig. 6A and B. (A) Photograph of a representative exper-
iment (one of four). The cells were fixed and stained with methylene blue.
(B) Duplicate plates were trypsinized and cell numbers were counted by
hemocytometer. Shown is a quantitative analysis of the compiled cell
numbers generated from the four experiments.
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presented here is a superior technique for mimicking the in
vivo situation and whenever possible we will use this tech-
nique in future studies.
Materials and methods
Cell lines
Human 3A trophoblasts (ATCC CRL1583) were grown
at 39°C in Dulbecco’s modified Eagle’s medium (DMEM)
with 7% fetal bovine serum. These temperature-sensitive
SV40 large T antigen-containing cells are mortal and have
normal trophoblast traits (e.g., synthesize human chorionic
gonadotropin and alkaline phosphatase) at 39°C (Chou,
1978). The 3A cultures were also heterogeneous in nature,
containing both cytotrophoblasts (small precursor cells) and
syncytiotrophoblasts (large, mature, multinucleated cells).
Human fibroblasts (ATCC CCL-110), RL95 (endometrial
carcinoma cell line, ATCC CRL-110), and HEC (endome-
trial carcinoma cell line, ATCC HTB-112) were grown in
DMEM with 7% fetal bovine serum at 37°C in 5% CO2.
HPV-31b infection of 3A trophoblast
HPV-31b virus stock was generated by mincing and
grinding 12-day-old skin rafts generated from CIN612 9E,
abbreviated to “612” hereafter, cells which harbor episomal
HPV-31b (Meyers et al., 1992; Meyers, 1996). Briefly, 612
cells were trypsinized and seeded onto collagen rafts con-
taining J2 fibroblasts as described to generate an organo-
typic epithelial raft culture system. HPVs are known to
productively replication in this system. Twelve days after
raising the raft to the air interface the raft tissues were
harvested, minced, and homogenized in DMEM. The rough
virus stocks were treated with DNase 1 and titered contain-
ing approximately 108 eg/ml (Fig. 2).
We also use cesium chloride (CsCl) to purify the HPV-
31b virus (Ozbun, 2002). CsCl was added to the rough virus
stocks at the density at 1.3 g/ml. A gradient was formed by
ultracentrifugation at 135,000 g for 24 h at 4°C. The tube
was punctured and 1-ml fractions were collected from the
bottom. One-tenth a milliliter of each fraction and 0.1 ml of
the rough cell lysate (without CsCl purification) were used
for harvesting DNA, which was then used to do a Southern
blot hybridization with 32P-HPV-31b DNA (Fig. 2B). The
highest HPV-31b virus containing fraction (Fraction 8) was
dialyzed by a Ultrafree-15 centrifugal filter device with 10K
NMWL Membrane (Millipore Corp., Bedford, MA). After
removal of the initial salt by three wash cycles with PBS at
2000 g centrifugation at 4°C, the purified HPV-31b virus
was stored at 80°C.
To infect 3A cells, 2 106 eg HPV-31b virus were taken
to put into 1  105 3A trophoblast medium overnight. The
next day the cells were trypsinized (this can also remove
unabsorbed virus from the cell surface) and replated in fresh
medium.
To characterize and neutralize the HPV-31 virus made
from rafts, an antibody neutralization experiment was un-
dertaken. The HPV-31b virus stocks were mixed with H31.A6
(HPV-31b neutralizing antibody) or H6.B10.5(HPV-6 neutral-
izing antibody), both provided by Dr. Neil Christensen (Chris-
tensen et al., 1996; Roden et al., 1997). After 1-h incubations,
these virus stocks (amount as indicated) were used to infect 3A
trophoblasts. At various times postinfection the cells were
harvested for total DNA for Southern blot analysis. In other
Fig. 9. Defective adhesion of HPV-31b-infected trophoblasts to HEC
endometrial cells. 3A cell lines were untreated or infected with HPV-31b
virus, then 51Cr-labeled, and assayed for binding to an established HEC
endometrial cell monolayers as described under Materials and methods.
“Lysate” refers to treatment with CIN612 monolayer lysates and is a
negative control for HPV-31 virus infection, which is also a cell lysate but
contains the virus. A lymphoblastoid cell line served as a negative control
and a fibroblast cell line as a positive control. Note that HPV-31b, by viral
infection, results in defective binding of 3A cells to the HEC monolayer
endometrial cells. This effect could be inhibited by neutralizing anti-
HPV-31 antibodies. A and B refer to the results after 1 or 3 h coincubation,
respectively. (C) PCR analysis of HPV DNA in starting, nonadherent, and
adherent HPV-infected 3A cells. Note that both endometrial-bound and
unbound HPV-31-infected 3A trophoblasts were positive for HPV-31.
However; the level of HPV-31 DNA was higher in the unbound cells.
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experiments the cells were fixed by formalin, stained with
methylene blue, and analyzed by densitometer.
Analysis of HPV-31b DNA replication by Southern blot
Twenty micrograms of the total cellular DNA from
HPV-31b-infected 3A cells were digested with EcoRI. Re-
sulting DNA was then agarose gel electrophoresed, South-
ern blotted, and probed with 32P-HPV-31b DNA (Liu et al.,
2001).
RT-PCR analysis of HPV-31b transcripts
HPV-31b mRNA expression was measured by RT-PCR,
along with a cellular mRNA control. 3A cells were infected
at day 0 and total RNA was isolated at the indicated days
using Trizol reagent (Gibco-BRL Life Technologies Inc.),
according to the manufacturer’s protocol, and treated with 5
U/ug of RNase-free DNase I at 37°C for 1 hr. Messenger
RNA was then separated using the Oligotex mRNA Mini
Kit (Qiagen Inc.) according to the supplier’s instruction. A
control RT-PCR analysis of expression of the housekeeping
gene TFIIB (Liu et al., 2001) was also undertaken. The
products were then analyzed on an agarose gel, stained with
ethidium bromide, and visualized by ultraviolet light. The
HPV-31b E6 primer set used was 5-TGAACTAAGCTCG-
GCATTGG-3 and 5-TTCAGTACGAGGTCTTCTCC-3,
which targeted amplification of the HPV-31 sequences from
nt 146 to 545. The L1 primer set used was 5-GCM-
CAGGGWCATAAYAATGG-3 and 5-CGTCCMARRG-
GAWACTGATC-3 (Bauer et al., 1991), which targeted
amplification of the HPV-31 sequences from nt 6500 to
6951. E1ˆE4 primer set used was 5-GCAGAACCGGACA-
CATCC-3 which corresponds to nt 692 to 709, and 5-
GGTGTTTCTGTGCTCTGG-3, which corresponds to nt
3440 to 3457 of HPV-31b. The expected product size for
spliced E1ˆE4 transcript is 349 bp.
Fluorescent antibody cell scanning analyzes cellular
receptors
The receptors of the 3A trophoblasts were analyzed by
flourescent antibody cell sorting (FACS) analysis using a
primary antibody against antiintegrin a6 (BD Biosciences,
555735) and one against heparan/heparan sulfate antibodies
(Chemicon, MAB2040) according to the manufacturer’s
protocol. Antiisotype antbodies were used as controls.
In situ immnocytochemistry for L1 protein in infected
trophoblasts
Uninfected or HPV-31b infected 3A trophoblasts were
cultured in Chamber slides (Nunc, Lab-TeK). At 15 days
after infection, the cells were fixed with buffered formalin.
The endogeneous peroxidase activity was blocked by 0.3%
H2O2 for 30 min. After rinsing, the slides were placed with
1% serum for 30 min to block nonspecific binding site.
Incubated primary antibody (Chemicon, MAB837) was
1:100 diluted on slides for 2 h at 37°C. After PBS washing
three times, POD-conjugated second antibody was used to
incubate for 30 min. PBS washing was repeated three times,
and DAB solution was added until desired dark-brown color
staining was achieved. Noninfected and infected cells with-
out primary antibody incubation were used as negative
controls.
Infection and replication of HPV-6 in 3A trophoblasts
3A trophoblasts (1 106 cells) were infected with 0.5 ml
of HPV-6 virus stock (obtained from Dr. William Bonnez).
After 14 days postinfection, total cellular DNA was isolated
and Southern blotted with HPV-6.
Measuring 3A trophoblast growth
3A trophoblasts (1  104 cells) were cultured in 12-well
plates and infected with HPV-31 virus at an m.o.i. of 0.5, 5,
50, or 500 encapsidated genomes per cell, in quadruplicate.
Monolayer 612 cell lysates generated from similar CIN612
cell numbers as 612 cells from the raft, were used as a virus
negative control (they contain the HPV DNA, but not the
virus particles). Other cellular controls included primary
human fibroblasts and two uterine endometrial cell lines
(RL95 and HEC), which were infected with the same m.o.i.
of HPV-31b. After 15 days, all the cells were fixed by
formalin and stained with methylene blue and analyzed by
densitometric analysis.
Trophoblast-endometrial cell binding assay
This experiment was undertaken similar to that described
previously (Rhode and Carson, 1993; You et al., 2002).
Briefly, first, cultures of confluent HEC or RL95 cells were
prepared in 24-well plates. Next, suspensions of uninfected
or HPV-31b infected 3A cells or other control cells (2 105
cells/ml) were labeled by adding 50 uCi of 51Cr and incu-
bated for 60 min at 37°C. The labeled cells were then
washed three times with phosphate-buffered saline. The
51Cr cells were then added to the medium covering the
endometrial cells and incubated for 1 h or 3 h at 37°C. At
that time the medium and nonadherent cells were removed
and the monolayer was gently washed three times with
phosphate-buffered saline. The labeled 3A trophoblasts
which remained bound to HEC cells were then extracted by
the addition of 0.5 M NaOH and 1% SDS and measured by
liquid scintillation counting.
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